Hopcure

Breast cancer is the leading cause of cancer-related deaths in Asia, and Pakistan ranks highest in the region for mortality due to this disease. Hopcure is committed to changing this statistic by developing a low-cost, portable device (BCD) that detects breast cancer at an early stage. Early detection significantly reduces mortality rates. Our screening method is safe and radiation-free. The startup was incubated in Plan9's 12th cycle, where it received initial seed funding and developed its MVP (Minimum Viable Product). Currently, it is working on its second prototype, continuing to innovate and refine its technology.